SEARCH

SEARCH BY CITATION

REFERENCES

  • Bittel DC, Butler MG. 2005. Prader-Willi syndrome: Clinical genetics, cytogenetics and molecular biology. Expert Rev Mol Med 7: 120.
  • Butler MG. 1990. Prader-Willi syndrome: Current understanding of cause and diagnosis. Am J Med Genet 35: 319332.
  • Butler MG. 2009. Genomic imprinting disorders in humans: A mini-review. J Assist Reprod Genet 26: 477486.
  • Butler MG. 2011. Prader-Willi syndrome: Obesity due to genomic imprinting. Curr Genomics 12: 204215.
  • Butler MG, Butler RI, Meaney FJ. 1988. The use of skinfold measurements to judge obesity during the early phase of Prader-Labhart-Willi syndrome. Int J Obes 12: 417422.
  • Butler MG, Fischer W, Kibiryeva N, Bittel DC. 2008. Array comparative genomic hybridization (aCGH) analysis in Prader-Willi syndrome. Am J Med Genet A 146: 854860.
  • Butler MG, Haynes JL, Meaney FJ. 1991. Anthropometric study with emphasis on hand and foot measurements in the Prader-Willi syndrome: Sex, age and chromosome effects. Clin Genet 39: 3947.
  • Butler MG, Lee PDK, Whitman BY. 2006. Management of Prader-Willi syndrome. New York, NY: Springer-Verlag. 550 p.
  • Butler MG, Meaney FJ. 1987. An anthropometric study of 38 individuals with Prader-Labhart-Willi syndrome. Am J Med Genet 26: 445455.
  • Butler MG, Meaney FJ. 1991. Standards for selected anthropometric measurements in Prader-Willi syndrome. Pediatrics 88: 853860.
  • Butler MG, Meaney FJ, Palmer CG. 1986. Clinical and cytogenetic survey of 39 individuals with Prader-Labhart-Willi syndrome. Am J Med Genet 23: 793809.
  • Butler MG, Sturich J, Lee J, Myers SE, Whitman BY, Gold JA, Kimonis V, Scheimann A, Terrazas N, Driscoll DJ. 2011. Growth standards of infants with Prader-Willi syndrome. Pediatrics 127: 687695.
  • Butler MG, Thompson T. 2000. Prader-Willi syndrome: Clinical and genetic findings. Endocrinologist 10: 3S16S.
  • Cassidy SB, Driscoll DJ. 2009. Prader-Willi syndrome. Eur J Hum Genet 17: 313.
  • Cronk C, Crocker AC, Pueschel SM, Shea AM, Zackai E, Pickens G, Reed RB. 1988. Growth charts for children with Down syndrome: 1 month to 18 years of age. Pediatrics 81: 102110.
  • Davies PS, Evans S, Broomhead S, Clough H, Day JM, Laidlaw A, Barnes ND. 1998. Effect of growth hormone on height, weight, and body composition in Prader-Willi syndrome. Arch Dis Child 78: 474476.
  • de Onis M, Wijnhoven TM, Onyango AW. 2004. Worldwide practices in child growth monitoring. J Pediatr 144: 461465.
  • Eiholzer U, Gisin R, Weinmann C, Kriemler S, Steinert H, Torresani T, Zachmann M, Prader A. 1998. Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance. Eur J Pediatr 157: 368377.
  • Goldstone AP, Holland AJ, Hauffa BP, Hokken-Koelega AC, Tauber M. 2008. Recommendations for the diagnosis and management of Prader-Willi syndrome. J Clin Endocrinol Metab 93: 41834197.
  • Grummer-Strawn L, Reinold C, Krebs NF. 2010. Use of World Health Organization and CDC growth charts for children aged 0–59 months in the United States. Morb Mortal Wkly Rep 59: 115.
  • Haqq AM, Stadler DD, Jackson RH, Rosenfeld RG, Purnell JQ, LaFranchi SH. 2003. Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome. J Clin Endocrinol Metab 88: 22062212.
  • Hoybye C. 2007. Five-years growth hormone (GH) treatment in adults with Prader-Willi syndrome. Acta Paediatr 96: 410413.
  • Meaney FJ, Butler MG. 1987. Craniofacial variation and growth in the Prader-Labhart-Willi syndrome. Am J Phys Anthropol 74: 459464.
  • Meaney FJ, Butler MG. 1989. The developing role of anthropologists in medical genetics: Anthropometric assessment of the Prader-Labhart-Willi syndrome as an illustration. Med Anthropol 10: 247253.
  • Mogul HR, Lee PD, Whitman BY, Zipf WB, Frey M, Myers S, Cahan M, Pinyerd B, Southren AL. 2008. Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: Results from the United States multicenter trial. J Clin Endocrinol Metab 93: 12381245.
  • Myers SE, Carrel AL, Whitman BY, Allen DB. 2000. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome. J Pediatr 137: 4249.
  • Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL. 2002. Centers for Disease Control and Prevention 2000 Growth Charts for the United States: Improvements to the 1977 National Center for Health Statistics Version. Pediatrics 109: 4560.
  • Ritzen EM, Lindgren AC, Hagenas L, Marcus C, Muller J, Blichfeldt S. 1999. Growth hormone treatment of patients with Prader-Willi syndrome. Swedish Growth Hormone Advisory Group. J Pediatr Endocrinol Metab 12: 345349.
  • Rosenbloom ST, McGregor TL, Chen Q, An AQ, Hsu S, Dupont WD. 2010. Specialized pediatric growth charts for electronic health record systems: The example of Down syndrome. AMIA Annu Symp Proc 2010: 687691.
  • Rosenbloom ST, Qi X, Riddle WR, Russell WE, DonLevy SC, Giuse D, Sedman AB, Spooner SA. 2006. Implementing pediatric growth charts into an electronic health record system. J Am Med Inform Assoc 13: 302308.
  • Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Christiansen JS, Hoybye C. 2010. One year of growth hormone treatment in adults with Prader-Willi syndrome improves body composition: Results from a randomized, placebo-controlled study. J Clin Endocrinol Metab 95: 49434950.
  • Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Frystyk J, Christiansen JS, Hoybye C. 2011. Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome. Growth Horm IGF Res 21: 185190.
  • Spooner SA. 2007. Special requirements of electronic health record systems in pediatrics. Pediatrics 119: 631637.